Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

por Irina Isakova-Sivak, Jørgen de Jonge, Tatiana Smolonogina, Andrey Rekstin, Geert van Amerongen, Harry van Dijken, Justin Mouthaan, Paul Roholl, Victoria Kuznetsova, Elena Doroshenko, Vadim Tsvetnitsky, Larisa Rudenko
Publicado 2014

A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.

por Byron E E Martina, Petra van den Doel, Penelope Koraka, Geert van Amerongen, Gunther Spohn, Bart L Haagmans, Lisette B V Provacia, Albert D M E Osterhaus, Guus F Rimmelzwaan
Publicado 2011

T-Cell tropism of simian varicella virus during primary infection.

por Werner J D Ouwendijk, Ravi Mahalingam, Rik L de Swart, Bart L Haagmans, Geert van Amerongen, Sarah Getu, Don Gilden, Albert D M E Osterhaus, Georges M G M Verjans
Publicado 2013

Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques.

por Rik L de Swart, Martin Ludlow, Lot de Witte, Yusuke Yanagi, Geert van Amerongen, Stephen McQuaid, Selma Yüksel, Teunis B H Geijtenbeek, W Paul Duprex, Albert D M E Osterhaus
Publicado 2007

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

por Joost H C M Kreijtz, Yasemin Suezer, Gerrie de Mutsert, Geert van Amerongen, Astrid Schwantes, Judith M A van den Brand, Ron A M Fouchier, Johannes Löwer, Albert D M E Osterhaus, Gerd Sutter, Guus F Rimmelzwaan
Publicado 2009

Exacerbated innate host response to SARS-CoV in aged non-human primates.

por Saskia L Smits, Anna de Lang, Judith M A van den Brand, Lonneke M Leijten, Wilfred F van IJcken, Marinus J C Eijkemans, Geert van Amerongen, Thijs Kuiken, Arno C Andeweg, Albert D M E Osterhaus, Bart L Haagmans
Publicado 2010

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo

por Arwen F. Altenburg, Carolien E. van de Sandt, Bobby W. S. Li, Ronan J. MacLoughlin, Ron A. M. Fouchier, Geert van Amerongen, Asisa Volz, Rudi W. Hendriks, Rik L. de Swart, Gerd Sutter, Guus F. Rimmelzwaan, Rory D. de Vries
Publicado 2017

Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection

por Rik L. de Swart, Rory D. de Vries, Linda J. Rennick, Geert van Amerongen, Stephen McQuaid, R. Joyce Verburgh, Selma Yüksel, Alwin de Jong, Ken Lemon, D. Tien Nguyen, Martin Ludlow, Albert D. M. E. Osterhaus, W. Paul Duprex
Publicado 2017

Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses

por Christopher L. D. McMillan, Stacey T. M. Cheung, Naphak Modhiran, James Barnes, Alberto A. Amarilla, Helle Bielefeldt-Ohmann, Leo Yi Yang Lee, Kate Guilfoyle, Geert van Amerongen, Koert Stittelaar, Virginie Jakon, Celia Lebas, Patrick Reading, Kirsty R. Short, Paul R. Young, Daniel Watterson, Keith J. Chappell
Publicado 2021